Giantcode Corporations GC117 Technology

Giantcode is a biotech company focused on revolutionising cancer treatment based on our patent pending technologies. The company is located in London, U.K., and has dedicated its attention towards fighting deadly diseases and restoring health. Our goal is to enhance the lives of patients by discovering and developing breakthrough treatments for various cancer forms.

We have successfully developed the GC117 technology and our forward activities are to bring the technology to market. We are supported by experts, partners and investors in our efforts to transform our vision into a commercial reality. An experienced in-house research and development team, and alliances with large pharmaceutical and biotechnology companies will enable our success and ultimately save lives.